Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Hematoma × Sarcoma × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Classical hematology 1

Conditions

Sarcoma 8 Bone Neoplasms 3 Neoplasms 2 Breast Neoplasms 2 Venous Thromboembolism 1 Risk Reduction Behavior 1 Rhabdomyosarcoma 1 Prosthesis-Related Infections 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Mesothelioma, Malignant 1 Lymphoma 1 Hematoma 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1

Interventions

Enoxaparin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation

Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡